Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Yamanouchi presents new inhibitors of reverse Na+/Ca2+ exchange

Feb. 12, 2004

Comparable results in phase II head-to-head study of TA-1790 and Viagra

Feb. 11, 2004

New PDE5 inhibitors claimed by Janssen scientists

Feb. 9, 2004

European submission for YM-617 TOCAS

Feb. 4, 2004

NDA submission for YM-087 for hyponatremia

Feb. 4, 2004

NX-1207 produces significant clinical improvement in BPH

Feb. 2, 2004

Two novel series of prostanoid IP antagonists discovered at Bayer

Feb. 2, 2004

Takeda patent covers novel tachykinin antagonists with utility in urinary disorders

Jan. 30, 2004

Ro-1151240 in stress urinary incontinence

Jan. 29, 2004

Vanilloid agonists effective in detrusor hyperreflexia

Jan. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...